Home » Topics » Disease categories and therapies » Infection

Infection
RSS

AmB-cochleates compared to other AmB formulations in mouse systemic candidiasis

July 14, 2000

Different rifalazil regimens examined against M. tuberculosis in mice

July 13, 2000

Broad-spectrum antibacterial compounds emerge from Daiichi R&D

July 12, 2000

Shionogi presents new cephem antibiotics

July 11, 2000

Randomized study of tafenoquine as malaria chemoprophylaxis

July 11, 2000

Efficacy of FK-463 in disseminated azole-resistant candidiasis in mice

July 10, 2000

Newly discovered inhibitor of pestivirus replication may lead to new treatments for HCV

July 7, 2000

AmBisome approved in U.S. for cryptococcal meningitis in AIDS patients

July 7, 2000

GPC Biotech and Karo Bio to develop novel antibiotics

July 7, 2000

Antibacterial and antiprotozoal azalides designed by Pfizer

July 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...